Cybin, Inc. (TSE:CYBN) has released an update.
Cybin, Inc., a clinical-stage biopharmaceutical company focused on developing psychedelic-based treatments for mental health, will present at the Public Ventures Discovery Day in Dallas on March 19, 2024. CEO Doug Drysdale will engage in a fireside chat and connect with attendees, highlighting the company’s latest advancements. The event aims to introduce investors to promising deep-tech companies, with Cybin at the forefront of innovating mental healthcare solutions.
For further insights into TSE:CYBN stock, check out TipRanks’ Stock Analysis page.
